2,480,000
TB incidence in 2022
424,000
deaths from TB in 2022
325,000
children under 15 with TB in 2022
Our work in Africa
TREAT TB
Read more about TREAT TB (Technology, Research, Education and Technical Assistance for Tuberculosis), an ambitious initiative that was launched by The Union, seeking to contribute new knowledge regarding shorter, more tolerable treatment regimens for MDR-TB.
The Union has worked in Africa since 2006, providing grants and tobacco control technical support through the Bloomberg Initiative to Reduce Tobacco Use (BI) Grants Program.
Since 2002, The Union Uganda Office provides technical assistance to the National TB and Leprosy Programme in Uganda to strengthen interventions for prevention, diagnosis and treatment of tuberculosis (TB). The Union works with implementing partners across Uganda’s health system structure, providing TB and TB-HIV training.
Members of The Union Africa Region
The Union is divided into seven regions to provide a platform for addressing lung health and related issues from a regional perspective. This structure offers members opportunities to network with colleagues who face the same regional challenges and contributes to The Union's deep understanding of local issues.
The Union Africa Region is made up of both organisational and individual members.
UNION NEWS FROM THE africa REGION
The rationale for cancer to be made a notifiable disease in India
In this Short Communication (to be published in the Q2 issue of PHA), the authors explain why the Ministry of Health in India should make cancer a notifiable disease.
TB disability and multimorbidity at the onset of treatment in Kenya, Uganda, Zambia and Zimbabwe
Ahead of World TB Day, we present an article that assesses the burden of multimorbidity and the effectiveness of referral pathways at the start of TB treatment across Kenya, Uganda, Zambia and Zimbabwe
Evaluating disability, comorbidities and risk factors after TB treatment: an 18–24 month follow-up in China
Ahead of World TB Day, we present an article that assesses disability, comorbidities and risk factors after TB treatment in China.